XML 47 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
3 Months Ended
Oct. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock-based Awards Outstanding by Award Type
As of October 31, 2018, the following stock-based awards, by award type, were outstanding:
Stock options
1,590,045

Performance shares
260,262

RSUs and restricted stock
440,829

Share units
155,806

Total
2,446,942

Stock-based compensation for awards detailing where recorded in Condensed Consolidated Statement of Operations
Stock-based compensation for awards issued is reflected in the following line items in our Condensed Consolidated Statements of Operations:
 
 
Three months ended October 31,
 
 
2018
 
2017
Cost of sales
 
$
58,000

 
40,000

Selling, general and administrative expenses
 
905,000

 
654,000

Research and development expenses
 
83,000

 
53,000

Stock-based compensation expense before income tax benefit
 
1,046,000

 
747,000

Estimated income tax benefit
 
(228,000
)
 
(260,000
)
Net stock-based compensation expense
 
$
818,000

 
487,000

Summary of net stock-based compensation expense by award type
Stock-based compensation expense (benefit), by award type, is summarized as follows:
 
 
Three months ended October 31,
 
 
2018
 
2017
Stock options
 
$
171,000

 
267,000

Performance shares
 
406,000

 
112,000

RSUs and restricted stock
 
547,000

 
385,000

ESPP
 
52,000

 
45,000

Share units
 
(130,000
)
 
(62,000
)
Stock-based compensation expense before income tax benefit
 
1,046,000

 
747,000

Estimated income tax benefit
 
(228,000
)
 
(260,000
)
Net stock-based compensation expense
 
$
818,000

 
487,000

Summary of the Plan's activity relating to stock options
The following table summarizes the Plan's activity during the three months ended October 31, 2018:
 
 
Awards
(in Shares)
 
Weighted Average
Exercise Price
 
Weighted Average
Remaining Contractual
Term (Years)
 
Aggregate
Intrinsic Value
Outstanding at July 31, 2018
 
1,668,975

 
$
28.72

 
 
 
 
Exercised
 
(78,930
)
 
28.37

 
 
 
 
Outstanding at October 31, 2018
 
1,590,045

 
$
28.74

 
4.27
 
$
741,000

 
 
 
 
 
 
 
 
 
Exercisable at October 31, 2018
 
1,388,123

 
$
28.74

 
3.94
 
$
574,000

 
 
 
 
 
 
 
 
 
Vested and expected to vest at October 31, 2018
 
1,555,133

 
$
28.73

 
4.22
 
$
712,000

Summary of the Plan's activity relating to performance shares, RSUs, restricted stock and share units
The following table summarizes the Plan's activity relating to performance shares, RSUs, restricted stock and share units:
 
 
Awards
(in Shares)
 
Weighted Average
Grant Date
Fair Value
 
Aggregate
Intrinsic Value
Outstanding at July 31, 2018
 
818,438

 
$
19.78

 
 
Granted
 
177,908

 
34.27

 
 
Settled
 
(121,790
)
 
21.08

 
 
Forfeited
 
(17,659
)
 
27.23

 
 
Outstanding at October 31, 2018
 
856,897

 
$
22.44

 
$
23,925,000

 
 
 
 
 
 
 
Vested at October 31, 2018
 
216,718

 
$
27.71

 
$
6,051,000

 
 
 
 
 
 
 
Vested and expected to vest at October 31, 2018
 
819,625

 
$
22.58

 
$
22,884,000